| Name： | METHOTREXATE |
| CAS： | 133073-73-1 ;59-05-2 ;51865-79-3 |
| Synonyms： | L-(+)-N-(P-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)GLUTAMIC ACID ; MTX ; NSC 740 ; METHOTREXATE HYDRATE(1:X) ; RHEUMATREX ; METHOTREXATE, USP 98-102% ; 4-AMINO-10-METHYLFOLIC ACID ; METHYLAMINOPTERIN ; (+)-AMETHOPTERIN ; (2S)-2-[[4-[(2,4-DIAMINOPTERIDIN-6-YL)METHYL-METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID ; METHOTREXAT ; AMETHOPTERIN ; N-BISMETHYLPTEROYLGLUTAMIC ACID ; METHYLAMINOPTERINUM ; METHOTREXATE USP24, BP2000, EP3RD ANTINEOPLASTIC DRUGS ; (+)-4-AMINO-10-METHYLFOLIC ACID ; L-GLUTAMIC ACID,N-[4-[[(2,4-DIAMINO-6-PTERIDINYL)METHYL]METHYLAMINO]BENZOYL]-, HYDRATE (9CI) ; METHOTREXATE, USP 98-102% ; EMTEXATE ; (S)-2-(4-(((2,4-DIAMINOPTERIDIN-6-YL)METHYL)(METHYL)AMINO)BENZAMIDO)PENTANEDIOIC ACID ; METHYLAMINOPTERINE ; ANTIFOLAN ; (2S)-2-[(4-([(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO)PHENYL)FORMAMIDO]PENTANEDIOIC ACID ; L-AMETHOPTERIN ; L-METHOTREXATE ; TREXALL ; METHOTREXATE ; (S)-2-(4-[(2,4-DIAMINO-PTERIDIN-6-YLMETHYL)-METHYL-AMINO]-BENZOYLAMINO)-PENTANEDIOIC ACID ; L-(+)-AMETHOPTERIN ; N-(4-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)L-GLUTAMIC ACID ; N-(P-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)-L-(+)-GLUTAMIC ACID ; ABITREXATE ; METHOTREXATE USP24, BP2000, EP3RD ANTINEOPLASTIC DRUGS ; 4-AMINO-N10-METHYLPTEROYL-L-GLUTAMIC ACID |
| MDL.： | MFCD00064370 |
| H bond acceptor： | 13 |
| H bond donor： | 5 |
| Smile： | CN(Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O |
| InChi： | InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1 |
| InChiKey： | InChIKey=FBOZXECLQNJBKD-ZDUSSCGKSA-N |
Property |
|
| Comments： | GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA OTHER NOTES: SALES RESTRICTIONS MAY APPLY |
Safety information |
|
METHOTREXATE
TradePlatform@qq.com
| Supplier | ||
|---|---|---|
| Custom | info@chems.com.cn | +86 (0)187 533 888 68 |
- Next：METHOTREXATE HYDRATE
- Previous：MAGNESIUM SULFATE